作者：
C,Kyllesbech [1]
;
N,Trier [2]
;
F,Mughal [3]
;
P,Hansen [3]
;
M,Holmström [4]
;
D,El Fassi [5]
;
H,Hasselbalch [6]
;
V,Skov [6]
;
L,Kjær [6]
;
M,Andersen [7]
;
E,Ciplys [8]
;
R,Slibinskas [8]
;
J,Frederiksen [2]
;
P,Højrup [9]
;
G,Houen [10]
作者单位：
Department of Neurology, Valdemar Hansens vej 23, Rigshospitalet, Glostrup, Denmark; Institute of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, Odense M, Denmark.
[1]
Department of Neurology, Valdemar Hansens vej 23, Rigshospitalet, Glostrup, Denmark.
[2]
Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, Copenhagen Ø, Denmark.
[3]
National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Borgmester Ib Juuls Vej 25C, Copenhagen University Hospital, Herlev, Denmark; Department of Immunology and Microbiology, University of Copenhagen, Blegdamsvej 3B, Copenhagen, Denmark.
[4]
Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, Copenhagen N, Denmark.
[5]
Department of Hematology, Zealand University Hospital Roskilde, Sygehusvej 10, Roskilde, Denmark.
[6]
Department of Immunology and Microbiology, University of Copenhagen, Blegdamsvej 3B, Copenhagen, Denmark.
[7]
Institute of Biotechnology, University of Vilnius, Sauletékio al. 7, Vilnius, Lithuania.
[8]
Institute of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, Odense M, Denmark.
[9]
Department of Neurology, Valdemar Hansens vej 23, Rigshospitalet, Glostrup, Denmark; Institute of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, Odense M, Denmark. Electronic address: gunnar.houen@regionh.dk.
[10]
DOI
10.1016/j.retram.2023.103380
PMID
36738659
发布时间
2024-06-05
换一批
换一批
